Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Mean corpuscular hemoglobin

MTMR2 · rs566204

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−16, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 630,125 African American or Afro-Caribbean, African ancestry, European ancestry, East Asian ancestry, Hispanic or Latin American and South Asian ancestry individuals.

The effect The reported allele is A; the catalogue records no effect size ; p = 6 × 10−17.

How common The A allele had a frequency of about 36% in the people studied.

Where it sits Chromosome 11, band 11q21 — a synonymous change in MTMR2.

What ClinVar records

Classification Benign for Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4B1, Charcot-Marie-Tooth disease; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 11 submitters), last evaluated 2026-02-04. ClinVar record 260685 NM_016156.6(MTMR2):c.1131C>T (p.Thr377=)

Classification Uncertain significance; no assertion criteria provided (0 of 4 stars, 1 submitter). ClinVar record 637885 NM_016156.6(MTMR2):c.1131= (p.Thr377=)

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-10-19 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

AG
Korean KRGDB
A 30.1% · G 69.9%
Korean Korea4K
A 29.1% · G 70.9%
Korean Korea1K
A 29.4% · G 70.6%
Japanese ToMMo
A 32.9% · G 67.1%
Vietnamese
A 18.9% · G 81.0%
World gnomAD
A 28.0% · G 72.0%
World 1000 Genomes
A 20.9% · G 79.1%
World TOPMed
A 28.1% · G 72.0%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

A/A Two copies of the version the research linked to Mean corpuscular hemoglobin. That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Mean corpuscular hemoglobin. That is a smaller link than two copies.
G/G No copy of the version the research linked to Mean corpuscular hemoglobin. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Mean corpuscular hemoglobin (rs566204). MyGeneLog™. https://www.mygenelog.com/variants/rs566204

← See all variants